67 related articles for article (PubMed ID: 1974170)
1. Effects of gamma-oryzanol on serum lipids and apolipoproteins in dyslipidemic schizophrenics receiving major tranquilizers.
Sasaki J; Takada Y; Handa K; Kusuda M; Tanabe Y; Matsunaga A; Arakawa K
Clin Ther; 1990; 12(3):263-8. PubMed ID: 1974170
[TBL] [Abstract][Full Text] [Related]
2. Low-dose effect of simvastatin (MK-733) on serum lipids, lipoproteins, and apolipoproteins in patients with hypercholesterolemia.
Saku K; Sasaki J; Arakawa K
Clin Ther; 1989; 11(2):247-57. PubMed ID: 2736571
[TBL] [Abstract][Full Text] [Related]
3. Effect of dialysis type on serum lipids, apolipoproteins, and lipoproteins.
Kanbay M; Delibasi T; Kaya A; Aydogan T; Koca C; Akcay A; Duranay M; Yigitoglu R
Ren Fail; 2006; 28(7):567-71. PubMed ID: 17050239
[TBL] [Abstract][Full Text] [Related]
4. The role of exercise in modulating the impact of an ultralow-fat diet on serum lipids and apolipoproteins in patients with or at risk for coronary artery disease.
Marshall DA; Vernalis MN; Remaley AT; Walizer EM; Scally JP; Taylor AJ
Am Heart J; 2006 Feb; 151(2):484-91. PubMed ID: 16442919
[TBL] [Abstract][Full Text] [Related]
5. Effects of slow-release bezafibrate on serum lipids, lipoproteins, apolipoproteins, and postheparin lipolytic activities in patients with type IV and type V hypertriglyceridemia.
Saku K; Sasaki J; Arakawa K
Clin Ther; 1989; 11(3):331-40. PubMed ID: 2743372
[TBL] [Abstract][Full Text] [Related]
6. [Lipids, lipoproteins and apolipoproteins in normal newborns].
Casanueva V; Cid X; Chiang MT; Molina M; Ferrada MC; Pérez R; Casanueva P
Rev Med Chil; 1998 Sep; 126(9):1073-8. PubMed ID: 9922510
[TBL] [Abstract][Full Text] [Related]
7. A 52-week, randomized, open-label, parallel-group comparison of the tolerability and effects of pitavastatin and atorvastatin on high-density lipoprotein cholesterol levels and glucose metabolism in Japanese patients with elevated levels of low-density lipoprotein cholesterol and glucose intolerance.
Sasaki J; Ikeda Y; Kuribayashi T; Kajiwara K; Biro S; Yamamoto K; Ageta M; Kobori S; Saikawa T; Otonari T; Kono S
Clin Ther; 2008 Jun; 30(6):1089-101. PubMed ID: 18640465
[TBL] [Abstract][Full Text] [Related]
8. Simvastatin in the treatment of hypercholesterolemia in elderly patients.
Antonicelli R; Onorato G; Pagelli P; Pierazzoli L; Paciaroni E
Clin Ther; 1990; 12(2):165-71. PubMed ID: 2354486
[TBL] [Abstract][Full Text] [Related]
9. A 12-week, prospective, open-label analysis of the effect of rosuvastatin on triglyceride-rich lipoprotein metabolism in patients with primary dyslipidemia.
Kostapanos MS; Milionis HJ; Filippatos TD; Nakou ES; Bairaktari ET; Tselepis AD; Elisaf MS
Clin Ther; 2007 Jul; 29(7):1403-14. PubMed ID: 17825691
[TBL] [Abstract][Full Text] [Related]
10. Effects of pindolol on serum lipids, apolipoproteins, and lipoproteins in patients with mild to moderate essential hypertension.
Sasaki J; Saku K; Ideishi M; Arakawa K; Kato Y; Kuwano E; So T
Clin Ther; 1989; 11(2):219-24. PubMed ID: 2736568
[TBL] [Abstract][Full Text] [Related]
11. Lipids, lipoproteins and apolipoproteins among turks, and impact on coronary heart disease.
Onat A
Anadolu Kardiyol Derg; 2004 Sep; 4(3):236-45. PubMed ID: 15355827
[TBL] [Abstract][Full Text] [Related]
12. Effects of glibenclamide on serum lipids, lipoproteins, thromboxane, beta-thromboglobulin, and prostacyclin in non-insulin-dependent diabetes mellitus.
Waysbort J; Regitz G; Chaimowitz D; Tuval M; Nakash I; Brunner D
Clin Ther; 1988; 10(4):358-71. PubMed ID: 2978874
[TBL] [Abstract][Full Text] [Related]
13. Effects of rosuvastatin versus atorvastatin, simvastatin, and pravastatin on non-high-density lipoprotein cholesterol, apolipoproteins, and lipid ratios in patients with hypercholesterolemia: additional results from the STELLAR trial.
Jones PH; Hunninghake DB; Ferdinand KC; Stein EA; Gold A; Caplan RJ; Blasetto JW;
Clin Ther; 2004 Sep; 26(9):1388-99. PubMed ID: 15531001
[TBL] [Abstract][Full Text] [Related]
14. Effect of pirozadil on lipids, lipoproteins and apolipoproteins in Japanese with type IIa hyperlipoproteinemia.
Shinomiya M; Ishikawa Y; Shirai K; Saito Y; Yoshida S
Arzneimittelforschung; 1987 Sep; 37(9):1069-71. PubMed ID: 3435604
[TBL] [Abstract][Full Text] [Related]
15. Effect of lovastatin on serum lipids in patients with nonfamilial primary hypercholesterolemia.
Itskovitz HD; Flamenbaum W; De Gaetano C; Pritchard KA; Stemerman MB
Clin Ther; 1989; 11(6):862-72. PubMed ID: 2611825
[TBL] [Abstract][Full Text] [Related]
16. Relation of clinical benefit of raising high-density lipoprotein cholesterol to serum levels of low-density lipoprotein cholesterol in patients with coronary heart disease (from the Bezafibrate Infarction Prevention Trial).
Goldenberg I; Benderly M; Sidi R; Boyko V; Tenenbaum A; Tanne D; Behar S
Am J Cardiol; 2009 Jan; 103(1):41-5. PubMed ID: 19101227
[TBL] [Abstract][Full Text] [Related]
17. Effects of desogestrel and gestodene in low-dose oral contraceptive combinations on lipid and lipoprotein status. A randomized prospective study.
Granata A; Sobbrio GA; D'Arrigo F; Barillari M; Curasì MP; Egitto M; Trimarchi F; Granese D; Pullè C
Acta Eur Fertil; 1990; 21(3):143-6. PubMed ID: 2149913
[TBL] [Abstract][Full Text] [Related]
18. The dual peroxisome proliferator-activated receptor alpha/gamma agonist tesaglitazar further improves the lipid profile in dyslipidemic subjects treated with atorvastatin.
Tonstad S; Retterstøl K; Ose L; Ohman KP; Lindberg MB; Svensson M
Metabolism; 2007 Sep; 56(9):1285-92. PubMed ID: 17697874
[TBL] [Abstract][Full Text] [Related]
19. [The effects of the short-term regular exercise-diet program on lipid profile in sedentary subjects].
Yalin S; Gök H; Toksöz R
Anadolu Kardiyol Derg; 2001 Sep; 1(3):179-8, AXV. PubMed ID: 12101821
[TBL] [Abstract][Full Text] [Related]
20. Inflammatory/antiinflammatory properties of high-density lipoprotein distinguish patients from control subjects better than high-density lipoprotein cholesterol levels and are favorably affected by simvastatin treatment.
Ansell BJ; Navab M; Hama S; Kamranpour N; Fonarow G; Hough G; Rahmani S; Mottahedeh R; Dave R; Reddy ST; Fogelman AM
Circulation; 2003 Dec; 108(22):2751-6. PubMed ID: 14638544
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
